Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

CD248 (Endosialin) is a type 1 membrane protein involved in developmental and pathological angiogenesis through its expression on pericytes and regulation of PDGFRβ signalling. Here we explore the function of CD248 in skeletal muscle angiogenesis. Two distinct forms of capillary growth (splitting and sprouting) can be induced separately by increasing microcirculatory shear stress (chronic vasodilator treatment) or by inducing functional overload (extirpation of a synergistic muscle). We show that CD248 is present on pericytes in muscle and that CD248-/- mice have a specific defect in capillary sprouting. In contrast, splitting angiogenesis is independent of CD248 expression. Endothelial cells respond to pro-sprouting angiogenic stimulus by up-regulating gene expression for HIF1α, angiopoietin 2 and its receptor TEK, PDGF-B and its receptor PDGFRβ; this response did not occur following a pro-splitting angiogenic stimulus. In wildtype mice, defective sprouting angiogenesis could be mimicked by blocking PDGFRβ signalling using the tyrosine kinase inhibitor Imatinib mesylate. We conclude that CD248 is required for PDGFRβ-dependant capillary sprouting but not splitting angiogenesis, and identify a new role for CD248 expressed on pericytes in the early stages of physiological angiogenesis during muscle remodelling.

Original publication

DOI

10.1371/journal.pone.0107146

Type

Journal article

Journal

Plos one

Publication Date

2014

Volume

9

Keywords

Adrenergic alpha-1 Receptor Antagonists, Angiopoietin-2, Animals, Antigens, CD, Benzamides, Capillaries, Hypoxia-Inducible Factor 1, alpha Subunit, Imatinib Mesylate, Mice, Mice, Knockout, Muscle, Skeletal, Neoplasm Proteins, Neovascularization, Physiologic, Pericytes, Piperazines, Platelet-Derived Growth Factor, Prazosin, Protein Kinase Inhibitors, Pyrimidines, Receptors, Platelet-Derived Growth Factor, Signal Transduction, Up-Regulation